SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $16,000 | -15.8% | 679 | -24.7% | 0.01% | -21.4% |
| Q1 2021 | $19,000 | -13.6% | 902 | +1.5% | 0.01% | -17.6% |
| Q4 2020 | $22,000 | -33.3% | 889 | -24.6% | 0.02% | -37.0% |
| Q3 2020 | $33,000 | +450.0% | 1,179 | -11.6% | 0.03% | +440.0% |
| Q2 2020 | $6,000 | +20.0% | 1,334 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $5,000 | +25.0% | 1,334 | +4.1% | 0.01% | -37.5% |
| Q4 2019 | $4,000 | -20.0% | 1,281 | +5.2% | 0.01% | -27.3% |
| Q3 2019 | $5,000 | +25.0% | 1,218 | -5.6% | 0.01% | +10.0% |
| Q2 2019 | $4,000 | -20.0% | 1,290 | +84.5% | 0.01% | -58.3% |
| Q1 2019 | $5,000 | – | 699 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |